However, practical experience suggests both approaches produce beneficial outcomes, with the choice often driven by convenience rather than optimization concerns
What makes Mounjaro different from semaglutide-based products is that it activates two hormone receptors at once: the GLP-1 receptor (which Ozempic and Wegovy target) and the GIP receptor (which plays a role in how the body processes fat and regulates insulin response)
This affects the entire physiology of a human, but for our purposes, can impose negative influences on the entire reproductive systems of men and women
Richards FO, McNeely MB, Bryan RT, et al
Zepbound combines GLP-1 and GIP to provide enhanced weight loss results, while Semaglutide GLP-1 and Wegovy are variations of the same medication, with Wegovy being a higher dose for chronic weight management
"You don't measure vulnerability by the amount of disclosure," she says